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Abstract
Myocardial fibrosis can lead to heart failure and act as a substrate for cardiac arrhythmias. In dilated cardiomyopathy diffuse
interstitial reactive fibrosis can be observed, whereas arrhythmogenic cardiomyopathy is characterized by fibrofatty
replacement in predominantly the right ventricle. The p.Arg14del mutation in the phospholamban (PLN) gene has been
associated with dilated cardiomyopathy and recently also with arrhythmogenic cardiomyopathy. Aim of the present study is
to determine the exact pattern of fibrosis and fatty replacement in PLN p.Arg14del mutation positive patients, with a novel
method for high resolution systematic digital histological quantification of fibrosis and fatty tissue in cardiac tissue.
Transversal mid-ventricular slices (n = 8) from whole hearts were collected from patients with the PLN p.Arg14del mutation
(age 48616 years; 4 (50%) male). An in-house developed open source MATLAB script was used for digital analysis of
Masson’s trichrome stained slides (http://sourceforge.net/projects/fibroquant/). Slides were divided into trabecular, inner
and outer compact myocardium. Per region the percentage of connective tissue, cardiomyocytes and fatty tissue was
quantified. In PLN p.Arg14del mutation associated cardiomyopathy, myocardial fibrosis is predominantly present in the left
posterolateral wall and to a lesser extent in the right ventricular wall, whereas fatty changes are more pronounced in the
right ventricular wall. No difference in distribution pattern of fibrosis and adipocytes was observed between patients with a
clinical predominantly dilated and arrhythmogenic cardiomyopathy phenotype. In the future, this novel method for
quantifying fibrosis and fatty tissue can be used to assess cardiac fibrosis and fatty tissue in animal models and a broad
range of human cardiomyopathies.
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Introduction
A network of extracellular matrix maintains the structural
integrity of the myocardium. Due to several etiologies increased
deposition of collagen and other extracellular matrix proteins can
occur leading to cardiac fibrosis [1]. After myocardial infarction,
cardiomyocytes are replaced by connective tissue leading to
reparative fibrosis. In contrast, in nonischemic cardiomyopathies,
an increase in collagen synthesis by myofibroblasts results in
diffuse interstitial reactive fibrosis. In arrhythmogenic cardiomy-
opathy (AC), fibrosis is accompanied by an increase of adipocytes
leading to so-called fibrofatty replacement [2].
Myocardial fibrosis is an important part of the histological
characteristics in heart failure with preserved and reduced ejection
fraction and may act as a substrate for cardiac arrhythmias.
Adequate detection of the amount and distribution of fibrosis in
the heart is important for diagnosis, predicting prognosis,
treatment planning and follow-up after therapy [3,4]. The
reference noninvasive standard for indirect detection of myocar-
dial fibrosis is late gadolinium enhancement on cardiac magnetic
resonance imaging (MRI) [3]. Thus far, detailed histological
correlation studies to validate this MRI technique are scarce.
Histological assessment of cardiac fibrosis is mostly limited by the
small amount of tissue available in diagnostic endomyocardial
biopsies that only provides regional information [2]. In addition,
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quantification of histological fibrosis is usually performed semi-
quantitatively, classifying the fibrosis in limited categories.
Phospholamban is a protein in the sarcoplasmic reticulum and
acts as a (reversible) inhibitor of the Ca2+ pump: sarcoplasmic
reticulum Ca2+-ATPase 2a (SERCA2a). On phosphorylation it
dissociates from SERCA2a and thereby activates the Ca2+ pump.
This cascade regulates cardiac relaxation and contractility. Several
causal phospholamban (PLN) mutations have been described in
humans [5–8]. The p.Arg14del (c.40_42delAGA) founder muta-
tion in the PLN gene has been associated with dilated cardiomy-
opathy (DCM) and recently also with AC [9]. Detailed histologic
analysis of the pattern of fibrosis and fatty changes in PLN
mutation associated cardiomyopathies has not been extensively
studied and to the best of our knowledge has not been performed
on transverse heart slices.
The aim of this study was to determine the exact patterns of
fibrosis and fatty changes in the myocardium of patients with the
PLN p.Arg14del mutation associated cardiomyopathy in relation
to their clinical phenotype. This study population was used as
proof-of-principle for a novel method of high resolution systematic
digital quantification of fibrosis and fatty tissue in transversal
cardiac slides. In the future this method may be used for detailed
histological quantification and determination of the distribution
pattern of cardiac fibrosis in different types of heart disease, in
addition it provides a detailed high resolution reference for
imaging techniques of cardiac fibrosis.
Methods
Ethics statement
The study met the criteria of the code of proper use of human
tissue that is used in the Netherlands. The study was approved by
the scientific advisory board of the biobank of the University
Medical Center Utrecht, Utrecht, the Netherlands (protocol
no. 12/387). Written informed consent was obtained or in certain
cases waived by the ethics committee when obtaining informed
consent was not possible due to death of the patient.
Hearts obtained at autopsy (n = 2) or explantation (n= 6) were
collected from patients with the PLN p.Arg14del mutation. Based
on their initial clinical presentation, patients were divided in two
categories: predominantly DCM or AC. Three control hearts, two
donor hearts not-used for transplantation and one heart obtained
at autopsy of a road accident victim, were used as reference.
We used a systematic methodology for high resolution digital
cardiac fibrosis quantification (Fig. 1). Hearts were cut in
transverse (short-axis) slices of 1 cm thick starting at the apex
including both ventricles. Each fourth transverse slice was fixed in
formalin and divided into smaller pieces. A map of the heart slice
was drawn to annotate the origin of each tissue specimen.
Subsequently the samples were embedded in paraffin and
Masson’s trichrome staining was performed. The slides were
scanned at 206magnification as described previously [10]. Images
were extracted using Aperio ImageScope v12.0.0.5039 (Aperio,
Vista, California, United States) as a TIFF file with lossless
compression. The images were resized to 10% of their original size
for digital analysis.
To analyze the cardiac tissue, slides were divided into several
layers: the epicardial area, compact myocardium and non-
compact (trabeculated) myocardium (http://sourceforge.net/
projects/fibroquant/). The epicardial area was defined as the
outer region of fatty tissue bordered by the first row of
cardiomyocytes. The non-compact myocardial area was defined
as the endocardial trabeculated region. The compact myocardium
was defined by the area between the trabeculated area and the
epicardial area and was artificially divided with an equidistant line
in two halves. An equidistant line is one for which every point on
the line is equidistant from the nearest points on both the
epicardial and trabecular segmentation. In case a midline division
was not feasible, e.g., due to a thin wall or originating from the
interventricular septum (without epicardium), mean values of the
total myocardium were used. Thus, the myocardium was divided
in four layers: trabecular myocardium, inner or outer compact
myocardium and the epicardium.
In all four layers the percentage of connective tissue (blue),
cardiomyocytes (red) and adipose tissue (cells with non stained
cytoplasm) was digitally quantified using MATLAB (Release
R2012a, The MathWorks, Inc., Natick, Massachusetts, United
States). The percentage per region was calculated by separating
the Masson’s trichrome stained slides into its constituent stains of
methyl blue and ponceau-fuchsin by performing color deconvolu-
tion [11]. This produces two grayscale images depicting the
concentration of the two stainings. The resulting images are
filtered using a 2D median filter and further processed using
morphological dilation, thresholding and closing operations. The
adipose tissue is quantified using a separate function in order to
highlight the ‘‘chain-link’’ structure of adipocytes as seen on glass
slides. The original image is converted to grayscale and filtered
using a 2D median filter. After that a threshold is applied and
morphological opening is performed. The median filtered image is
then subtracted from the morphologically opened image and the
resulting image is further morphologically processed by perform-
ing consecutive closing and opening operations. This converts the
‘‘chain-link’’ structure into a black and white image where only the
adipose tissue is left. The area of each constituent is determined
and a percentage is calculated based on the total area that was
processed [12]. The epicardial region was excluded from analysis.
The resulting values (percentage fibrosis and fatty tissue) were
annotated to the corresponding region in the heart using an
automated algorithm (Fig. S1).
Subsequently the annotated map of the transverse slice is
automatically transformed to a standardized schematic overview.
The annotated map was translated to a schematic overview by
determining the angular properties of each separate section from
the middle of the ventricles with a precision of one degree. The
results of the quantification (percentage fibrosis or fatty tissue) are
displayed using an easily interpretable color scale. Statistics were
performed using IBM SPSS Statistics (Version 20.0, IBM
Corporation, Armonk, New York, United States). We compared
mean percentages of fibrosis and adipose tissue in different areas
between the two clinical phenotypes of AC and DCM and control
hearts. The left ventricle was divided into a septal, posterior,
posterolateral, lateral, anterolateral and anterior part. The right
ventricle was divided into a posterior and anterior part. To
compare mean percentages of fibrosis and adipose tissue corrected
for surface area per region and condition a repeated measures
analysis was performed. After Greenhouse-Geisser correction,
interactions between region and condition were explored. Post hoc
tests (Tukey HSD) were performed in the absence of a significant
interaction.
Results
Clinical characteristics of the patients are summarized in
Table 1. Mean age was 48616 years; 4 (50%) patients were
male. Five patients were known with a clinical phenotype of DCM
and 3 patients were known with a clinical phenotype of AC. The
schematic overviews depict distribution and percentage of fibrosis
and adipose tissue for DCM (Fig. 2) and arrhythmogenic patients
Cardiac Digital Histological Quantification
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(Fig. 3). Mean values of fibrosis and adipose tissue with standard
deviations per region and condition (control, AC or DCM) are
presented in Table S1. In the 8 heart slices of PLN mutation
carriers, myocardial fibrosis was mainly observed in the trabecular
part of the posterolateral wall of the right ventricle and in the
posterolateral (mean .38%) and in lesser extent anterolateral
(mean .26%) wall of the left ventricle. In the left ventricle, fibrosis
was more pronounced in the outer layer of compact myocardium
than in the myocardial layers more closely to the lumen. Mean
percentage of fibrosis and adipose tissue is shown in the combined
schematic overviews (Fig. 4). The septum and ventral wall of the
right ventricle revealed the least amount of interstitial fibrosis.
Fatty changes of myocardium were predominantly observed in the
entire right ventricle wall (mean 37.2614% and 28.964% in AC
and 26.1620% and 24.3612% in DCM respectively in regions 7
and 8) and in the epicardial side of the left ventricular
posterolateral wall compact myocardium (mean 6.965% in AC
and 5.866% in DCM in region 1). Overall fatty infiltration of
myocardium was more pronounced in the right (mean adipose
tissue .24%) than in the left (mean adipose tissue ,11%)
ventricle. In control hearts, mean fibrosis was less than 6%, mean
adipose tissue was 2% or less in the left ventricle myocardium and
less than 15% in the right ventricular wall (Fig. 5).
Mean connective and adipose tissue per condition and region
(n = 8, corrected for surface area) is shown in boxplots (Fig. 6).
Mean values of fibrosis and adipose tissue were log transformed to
reduce right-skewness and heterogeneity of variance and a
repeated measures analysis was performed. Comparing fibrosis
we found a significant interaction between condition and region
(p,0.001), therefore post-hoc testing was not performed. For
Figure 1. Overview of methodology. LV, left ventricle; RV, right ventricle; Ant., anterior; Post., posterior. A, gross showing a transverse heart slice
of arrhythmogenic cardiomyopathy. B, transverse slice dissection scheme. C–F, examples of digital slide processing. Regions of interest are shown in
orange lines (defining the epicardium, compact myocardium divided by an equidistant midline and trabeculated part). C, slide from the left ventricle
posterior wall. D, slide C after digital processing. Red: cardiomyocytes. Blue: connective tissue. Pseudo green: adipose tissue. E, slide from the right
ventricle lateral wall. F, slide E after digital processing. Red: cardiomyocytes. Blue: connective tissue. Pseudo green: adipose tissue.
doi:10.1371/journal.pone.0094820.g001
Table 1. Patient characteristics of the PLN p.Arg14del
mutation carriers.
(n =8)
Age; mean (SD) 48 (16)




Left ventricular assist device 4 (50%)
First presenting symptom
Arrhythmia 4 (50%)
Heart failure 4 (50%)
Heart transplantation 6 (75%)
SD, standard deviation; ICD, implantable cardioverter-defibrillator; CRT-D,
cardiac resynchronization therapy defibrillator.
doi:10.1371/journal.pone.0094820.t001
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adipose tissue there was no significant interaction between
condition and region (p= 0.470). We found no significant
difference between AC and DCM in pattern of adipose tissue
(p = 0.382). Compared to controls, we found a higher percentage
of adipose tissue in AC (p= 0.028) and a trend for a higher
percentage of adipose tissue in DCM (p= 0.126).
Discussion
To the best of our knowledge this is the first study that provides
the exact and detailed pattern of fibrosis and fatty changes in PLN
p.Arg14del mutation associated cardiomyopathy hearts. For this
study we developed a novel method for systematic high resolution
digital quantification of different tissue types in the heart. This
Figure 2. Schematic heart slice overview of patients with a clinical phenotype of dilated cardiomyopathy. The results of the digital
quantification in heart slices in percentage of fibrosis or adipose tissue are shown using a color scale. The epicardial region has been excluded from
this overview. LV, left ventricle; RV, right ventricle; Ant., anterior; Post., posterior
doi:10.1371/journal.pone.0094820.g002
Figure 3. Schematic heart slice overview of patients with a clinical phenotype of arrhythmogenic cardiomyopathy. The results of the
digital quantification in heart slices in percentage of fibrosis or adipose tissue are shown using a color scale. The epicardial region has been excluded
from this overview. LV, left ventricle; RV, right ventricle; Ant., anterior; Post., posterior
doi:10.1371/journal.pone.0094820.g003
Cardiac Digital Histological Quantification
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quantification has been applied to Masson’s trichrome stained
slides of transverse cardiac slices in PLN p.Arg14del mutation
associated cardiomyopathies. Interestingly we found an overlap in
fibrosis and fatty changes between DCM and AC in PLN
p.Arg14del mutation carriers. Myocardial fibrosis was mainly
observed in the posterolateral wall of the left ventricle and in less
Figure 4. Schematic heart slice overview of patients with the PLN p.Arg14del mutation (dilated and arrhythmogenic
cardiomyopathy). The results of the mean percentage of fibrosis or adipose tissue are shown using a color scale. In total 102 heart slides of 8
heart slices were used. LV, left ventricle; RV, right ventricle; Ant., anterior; Post., posterior
doi:10.1371/journal.pone.0094820.g004
Cardiac Digital Histological Quantification
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extent in the posterolateral wall of the right ventricle. Fatty tissue
was more pronounced in the myocardium bordering the
epicardium of the right ventricle. We found a significant higher
percentage of adipose tissue in AC compared to control hearts
(p = 0.028).
Phospholamban is a regulator of the SERCA2a pump,
important for maintaining Ca2+ homeostasis and crucial for
cardiac contractility [6,13]. Phosphorylation of PLN increases
SERCA2a activity, leading to increased cardiac relaxation and
contractility for the next beat. The precise pathophysiological
mechanism in PLN p.Arg14del mutation carriers leading to
cardiac fibrosis and heart failure remains unknown. Transgenic
mice overexpressing the mutant PLN-R14del showed extensive
myocardial fibrosis, myocyte disarray, ventricular dilation and
premature death, recapitulating human cardiomyopathy [8]. Co-
expression of the normal and mutant protein in HEK-293 cells
resulted in SERCA2a super inhibition. From these results it was
inferred that the PLN p.Arg14del mutation causes inhibition of the
SERCA2a pump and thereby leads to disturbed calcium
metabolism and subsequently cardiac dysfunction. These data
show that this process of reactive fibrosis develops according to a
specific pattern, irrespective of the phenotype of the patients. Our
small sample size should thereby be taken into account and
because of a significant interaction post-hoc testing was not
feasible for comparing the mean fibrosis values. This varying
phenotype might by influenced by effect modifiers, e.g., epigenet-
ics or intense endurance exercise [14]. In addition, it has been
postulated that the pattern of reactive fibrosis is determined by
myocardial stress, microvascular dysfunction and sustained acti-
vation of neurohormonal and cytokine systems [15]. Future
research is needed to elucidate underlying pathophysiology in PLN
mutation carriers related to the phenotype.
Previous (not PLN mutation specific) histopathological studies
have shown similar areas of predilection in AC [16]. At first,
affected areas in the right ventricle (RV) were described as the
classic triangle of dysplasia, including the RV inflow tract, the apex
and the RV outflow tract [17]. Further research revealed that AC
is not isolated to the RV. In a clinicopathologic study by Corrado
et al. left ventricular involvement was found in 76% of cases with
AC affecting both the septum and LV free wall, with a predilection
for the posteroseptal and posterolateral areas [18]. A recent MRI
study in desmosomal mutation positive patients with AC showed
involvement of the basal inferior and anterior right ventricle and
the posterolateral left ventricle in AC, supporting the presence of a
new biventricular triangle in early AC [19]. Our results support
the evidence from experimental animal models that the disease
process in AC starts on the epicardial side and extends as a wave
front from the epicardium towards the endocardium [20]. Clinical
diagnosis of AC is made using International Task Force (revised)
criteria, including structural (MRI and echocardiogram), histolog-
ical (e.g. endomyocardial biopsy), electrocardiographic, arrhyth-
mic and genetic features [2]. The sensitivity of endomyocardial
biopsies from the right ventricular septum in AC is low, according
to our findings this might also be the case in PLN mutation
associated cardiomyopathies [21].
The method of fibrosis quantification presented here can be
used for several applications. First, determination of the fibrosis
pattern in the heart could provide an important link for genotype-
phenotype relationships in genetic cardiomyopathies. Previous
studies have proposed morphometric evaluation of either fibrosis
or adipocytes in different tissues [22–24]. In our analysis fibrosis
and fibrofatty replacement can be assessed simultaneously in layer
specific detail. We defined different regions of interest to divide the
heart in an epicardial, compact and trabeculated layer. In
Figure 5. Schematic overview of fibrosis and adipose tissue in heart slices of control hearts. The results of the digital quantification in
percentage of fibrosis or adipose tissue are shown using a color scale. The epicardial region has been excluded from the analysis. LV, left ventricle; RV,
right ventricle; Ant., anterior; Post., posterior
doi:10.1371/journal.pone.0094820.g005
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addition, the pattern of fibrosis can be studied in the different
regions of both ventricles. By studying the exact fibrosis pattern
throughout the heart, patterns of disease might be discovered
thereby elucidating mechanisms of pathophysiology. Numerous
disease-causing genes for different cardiomyopathies have been
identified during the past two decades and the challenge for the
future is to link these genetic mutations to specific patterns of
disease in the heart [20,25]. In future, AC with different
underlying causal mutations could be compared to the PLN
p.Arg14del mutation carriers with AC.
The second application could be validation of cardiac imaging
techniques. The reference noninvasive standard for fibrosis
detection is late gadolinium enhancement on MRI. [3] Adequate
correlation to the gold standard of histology is important. Thus far,
correlation studies are mostly done with small endomyocardial
biopsies that only represent a fraction of the total myocardium or
with triphenyl tetrazolium chloride (TTC) stained heart slices [26].
Recently, several novel techniques for fibrosis detection have been
proposed, including T1-mapping, that also require adequate
correlation to histology [3,27]. Cardiac MRI images obtained
before autopsy or heart transplantation, indicating fibrosis could
be divided in similar segments to produce a bull’s eye plot for
comparison with histopathological quantification. However, some
heart failure patients are ineligible for MRI because of implanted
devices, such as implantable cardioverter-defibrillator, cardiac
resynchronization therapy and left ventricular assist devices.
A third potential application could be systematic fibrosis
quantification in animal models, for example in models of
ischemic [28] or nonischemic cardiomyopathy [29]. Effects of
novel therapies on myocardial fibrosis can be examined in
randomized preclinical trials, by systematically comparing the
amount of fibrosis on histology. A standardized preclinical model
with induced myocardial infarction can be used to study new
therapeutics, such as cell therapy, as a strategy to attenuate cardiac
fibrosis and stop progression towards heart failure [30,31].
In conclusion, in PLN p.Arg14del mutation associated cardio-
myopathy myocardial fibrosis is predominantly present in the left
posterolateral wall, whereas fatty changes are more pronounced in
the wall of the right ventricle. In the analyzed heart slices from
PLN p.Arg14del mutation carriers with nonischemic cardiomyop-
athy we found an overlap in distribution pattern between patients
with DCM and AC and a significant higher percentage of adipose
tissue in AC compared to control hearts (p = 0.028). We developed
a novel method for systematic high resolution digital histological
quantification of fibrosis and fatty tissue in the heart. This method
can be used to assess cardiac fibrosis and fatty tissue in a broad
range of human cardiomyopathies, animal models and can serve
as gold standard for noninvasive imaging techniques.
Supporting Information
Figure S1 Schematic overview of Case 6 Arrhythmo-
genic Cardiomyopathy with representative images. A,B,
schematic heart slice overview of mean fibrosis (A) and adipose
tissue (B). Corresponding slide numbers are shown inside the inner
rings (n = 11). Mean percentage of fibrosis (A) or adipose tissue (B)
per area have been superimposed on the overview (values rounded
to the nearest whole number, values ,20% are shown in white to
improve readability). C,E,G, raw microscopic slide images after
Masson’s trichrome staining, respectively corresponding to slide 1,
5 and 7.D,F,H, corresponding slides after digital processing. Red:
cardiomyocytes. Blue: connective tissue. Pseudo green: adipose
tissue. The slides depicted in Figure 1C-F are also derived from
the same heart, 1C,D correspond to slide 3 and 1E,F correspond
to slide 10.
(TIF)
Table S1 Mean percentage of fibrosis and adipose
tissue per region and condition. Regions correspond to the
depicted regions in Figure 6C. AC, Arrhythmogenic Cardiomy-
opathy; DCM, Dilated Cardiomyopathy; SD, standard deviation.
(DOCX)
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